Bristol Myers Squibb Co. (BMY)
61.15
-0.31
(-0.50%)
USD |
NYSE |
Oct 02, 16:00
61.14
-0.01
(-0.02%)
After-Hours: 20:00
Bristol Myers Squibb Profit Margin (Quarterly) : 25.54% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.54% |
| March 31, 2026 | 23.31% |
| December 31, 2025 | 8.69% |
| September 30, 2025 | 17.96% |
| June 30, 2025 | 10.70% |
| March 31, 2025 | 21.98% |
| December 31, 2024 | 0.62% |
| September 30, 2024 | 10.22% |
| June 30, 2024 | 13.80% |
| March 31, 2024 | -100.4% |
| December 31, 2023 | 15.35% |
| September 30, 2023 | 17.64% |
| June 30, 2023 | 18.50% |
| March 31, 2023 | 20.00% |
| December 31, 2022 | 17.75% |
| September 30, 2022 | 14.33% |
| June 30, 2022 | 12.02% |
| March 31, 2022 | 11.01% |
| December 31, 2021 | 19.79% |
| September 30, 2021 | 13.35% |
| June 30, 2021 | 9.07% |
| March 31, 2021 | 18.32% |
| December 31, 2020 | -90.59% |
| September 30, 2020 | 17.82% |
| June 30, 2020 | -0.79% |
| Date | Value |
|---|---|
| March 31, 2020 | -7.11% |
| December 31, 2019 | -13.34% |
| September 30, 2019 | 22.74% |
| June 30, 2019 | 22.94% |
| March 31, 2019 | 28.97% |
| December 31, 2018 | 19.92% |
| September 30, 2018 | 33.60% |
| June 30, 2018 | 6.70% |
| March 31, 2018 | 28.79% |
| December 31, 2017 | -42.74% |
| September 30, 2017 | 16.29% |
| June 30, 2017 | 17.92% |
| March 31, 2017 | 30.96% |
| December 31, 2016 | 17.13% |
| September 30, 2016 | 24.69% |
| June 30, 2016 | 24.39% |
| March 31, 2016 | 27.47% |
| December 31, 2015 | -3.01% |
| September 30, 2015 | 17.94% |
| June 30, 2015 | -2.64% |
| March 31, 2015 | 29.67% |
| December 31, 2014 | 0.63% |
| September 30, 2014 | 18.67% |
| June 30, 2014 | 8.59% |
| March 31, 2014 | 24.56% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
| Merck & Co., Inc. | -8.06% |
| Pfizer Inc. | -1.64% |
| AstraZeneca PLC | 20.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 47.80% |
| Return on Assets | 10.18% |
| Return on Invested Capital | 13.74% |
| Gross Profit Margin (Quarterly) | 67.95% |
| Operating Margin (Quarterly) | 36.04% |
| Return on Net Operating Assets | 14.85% |